Impel NeuroPharma Stock

impelnp.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $122.85MM

Impel NeuroPharma is a biotechnology company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Impel NeuroPharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Impel NeuroPharma’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Impel NeuroPharma.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Jon Congleton
Chief Executive Officer, President & Board Member
Meghan Swardstrom
Vice President, Clinical Operations
Ellen Lubman
Chief Business Officer
Scott Youmans
Senior Vice President, Engineering
Mike Malafronte
Vice President of Quality Assurance
John Hoekman Ph.D
Co-Founder, Chief Scientific Officer & Board Member
Lynn Gold Ph.D
Senior Vice President, Regulatory
Stephen Shrewsbury
Chief Medical Officer

Board Members

Ali Satvat
Kohlberg Kravis Roberts
H. Stewart Parker
Mahendra Shah Ph.D
Vivo Capital
David Allison Ph.D
5AM Ventures
Diane Wilfong
John Hoekman Ph.D
Robert Mittendorff MD
Norwest Venture Partners
Aaron Royston MD
James Young Ph.D
5AM Ventures
Jon Congleton
Timothy Nelson

Impel NeuroPharma’s stock FAQs


Can you buy Impel NeuroPharma’s stock?

Impel NeuroPharma is not publicly traded on NYSE or NASDAQ in the U.S. To buy Impel NeuroPharma’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Impel NeuroPharma’s stock?

Yes, you can sell stock of a private company like Impel NeuroPharma. Forge can help you sell your Impel NeuroPharma stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Impel NeuroPharma’s stock price?

Impel NeuroPharma is a privately held company and therefore does not have a public stock price. However, you may access Impel NeuroPharma’s private market stock price with Forge Data.

What is Impel NeuroPharma’s stock ticker symbol?

Impel NeuroPharma does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Impel NeuroPharma : Announces Appointment Of Diane Wilfong To Board Of Directors

Impel NeuroPharma Closes $67.5M in Series D Financing | FinSMEs

Impel NeuroPharma, a biotech company focused on developing therapies for the treatment of CNS disorders, completed a $67.5m Series D financing
Updated on: Jul 12, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.